A new study highlights the importance of a more inclusive approach to drug testing, to ensure that it is effective across different ethnicities.
Research funded by Barts Charity, conducted at Queen Mary University of London and St Bartholomew's Hospital, has identified a gene variant that causes a common type of high blood pressure (known as hypertension) and proposes a cure which could help many people currently going undiagnosed.
In 2021, Barts Charity awarded Dr Michelle Lockley of Barts Cancer Institute, Queen Mary University of London, nearly £500,000 to investigate a new personalised treatment approach for ovarian cancer.
As a result of a surge in laughing gas abuse experienced in East London, researchers from the Barts Charity-funded Preventive Neurology Unit (Centre for Preventive Neurology as of September 2023) based at the Royal London Hospital, have published new treatment guidelines for wider NHS use.
New research finds that people from ethnic minority groups and socioeconomically deprived areas face higher risks of developing dementia. Funded by Barts Charity, the research is focused on better representing a diverse UK population.
This Breast Cancer Awareness month we’re shining a light on Dr Tamara Suaris and her important breast cancer research work.
In 2022, the Barts Health neuro-oncology service, who together with the Blizard Institute at Queen Mary University of London received £1.5m funding, was recognised as a Centre of Excellence by the Tessa Jowell Brain Cancer Mission.
With £2.6m of charity funding, researchers at Queen Mary University of London aim to better understand how metabolism affects obesity.
Barts Charity-funded study finds that in-school workshops could help children with asthma.
Today is World Parkinson’s Day, on which people around the world come together to raise awareness about Parkinson’s disease.
